Overview:
Bromelain is an enzyme that is known for its substantial contribution in food & beverage, cosmetics, and pharmaceuticals. The product can be derived from stem and fruit of pineapples. The improvement in technology marks a substantial transformation in the industrial grades and quality of bromelain. The global bromelain market has the potential to surpass a valuation of USD 1,055.1 million by 2025. The rise would see acquiring of 4.60% CAGR during the review period (2018-2025). Market Research Future (MRFR) discussed in the report that the bromelain market can ride on a demand for 579,958.3 kg by 2025 that would witness a rise by 6.54% CAGR during the forecast period.
Bromelain’s wide-scale growth can be attributed to its use in various end-user industries. The recent studies show that it can be used in prevention of cancer. It can trigger metastasizing. Technological boost has led to various innovative extraction method for bromelain. Nanoparticles are getting introduced to purify the substance and segregate it from the source. But its adverse side-effects can deter the bromelain market from having a regular growth.
Request a FREE Sample Copy of Report: https://www.marketresearchfuture.com/sample_request/7266
Segmentation:
The booming bromelain market report can be studied on the basis of source, type, and application.
By source, the bromelain market study can be segmented into stems and fruits. The stems segment had 88% of the global market share in 2017 from where it could go up to USD 931.6 million by 2025. The fruits segment comes with a potential to cross USD 123.4 million mark by 2025.
By type, the report on the bromelain market comprises 1,200 GDU/g, 2,000 GDU/g, 2,500 GDU/g, and others. The 2,000 GDU/g segment has the better chance for domination. The 2,500 GDU/g segment, with the highest CAGR of 4.94% during the review period, can cross a valuation mark of USD 281.3 million by 2025.
By application, the bromelain market includes healthcare, food & beverages, dietary supplements, and others. The dietary supplement has 39.6% coverage of the global market in 2017. Dietary supplements can rise by the highest CAGR over the review period to surpass the valuation mark of USD 425.0 million by 2025.
Regional Analysis:
North America and Europe are expected to show substantial market intake of bromelain. This can be attributed to their increasing awareness of the product, well-established meat industry, high traction from the pharmaceutical sector, better expenditure scope, various investors showing interest, and others. The meat tenderization process for the ready-to-eat segment in North America is expected to create strong demand for the bromelain market. Both these regions are also making a name for themselves by showing ample scope for bromelain to permeate as dietary supplements. Europe’s market would be the second best. North America had a market share of 35.5% in 2017. Europe can display a CAGR of 4.71% during the forecast period with a potential to surpass USD 343.3 million by 2025.
The APAC region would depend much on countries like Thailand, China, and Indonesia to substantially contribute to the global market profit. The region could witness an acquired CAGR of 5.02% during the forecast period. Various bromelain manufacturing units are getting established. India and China are expected to make sure that the market can increase its worth in the coming years.
Browse Report: https://www.marketresearchfuture.com/reports/bromelain-market-7266
Competitive Landscape:
There are several companies who are impacting the bromelain market in a robust way. MRFR’s analysis showcases various steps they undertake to make sure the market gains the most. Also, their strategic moves help them in obtaining a stronghold for themselves in the market. MRFR profiled these companies for a better understanding of the global market. These companies are Changsha Natureway Co., Ltd. (China), Creative Enzymes (U.S.), Enzyme Development Corporation (U.S.), Nutriteck (Canada), Enzybel Group (Belgium), Advanced Enzyme Technologies (India), Krishna Enzytech Pvt. Ltd. (India), Hong Mao Biochemicals Co., Ltd. (Thailand), Food State Company (U.K.), and Fooding Group Limited (China).
In September 2019, scientists claimed that bromelain can significantly impact osteoarthritis. The element, which is known for its digestive impacts, can also reduce the pain level of patients suffering from osteoarthritis.